Sopharma AD (BUL: SFA)
Health Care · Pharmaceuticals · BG
€2.08
+0.48% today · -16.1% 1Y
Sopharma AD (BUL: SFA) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.28B.
Over the last twelve months the share price has lost 16.1%, trading between 1.24 and 2.00.
Tweenvest scores Sopharma AD across four factors: quality 68/100, value 42/100, growth 86/100, dividend 53/100. Its strongest factor is growth.
SFA price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.28B
- Revenue (TTM)
- $1.61B
- P/E
- 9.03
- EPS
- 0.23
- Dividend yield
- 1.39%
- Beta (5Y)
- 0.08
- 52-week high
- €2.00
- 52-week low
- €1.24
- Avg volume (3M)
- —
- Shares outstanding
- 528.43M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,245.00 | -0.15% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $271.54 | -0.55% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $151.00 | +0.23% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.90 | +0.13% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.72 | +0.51% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.04 | +0.25% |
Figures last refreshed Aug 18, 2026.